Stay updated on OpACIN-neo Optimal Combo Trial

Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.
Latest website image capture
Clouds background image

Latest updates to the OpACIN-neo Optimal Combo Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T00:55:03.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of specific identifiers related to a clinical trial for Malignant Melanoma Stage III and the removal of detailed descriptions of the trial's methodology and inclusion criteria.
    Difference
    26%
    Check dated 2025-04-16T14:09:34.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T08:48:21.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:05:36.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:05:09.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:55:44.000Z thumbnail image

Stay in the know with updates to OpACIN-neo Optimal Combo Trial

Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.